Dr. Grossberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1438 S Grand Blvd
Saint Louis, MO 63104Phone+1 314-977-4829Fax+1 314-268-5494
Education & Training
- David P. Wohl Memorial Mental Health InstituteResidency, Psychiatry, 1977 - 1979
- SSM Health/Saint Louis University School of MedicineResidency, Psychiatry, 1976 - 1977
- Mercy Hospital (St Louis)Internship, Transitional Year, 1975 - 1976
- Saint Louis University School of MedicineClass of 1975
Certifications & Licensure
- IL State Medical License 1997 - 2026
- MO State Medical License 1976 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- St. Louis Magazine: Top Doctors Castle Connolly, 2001
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Current Screening Tests/Biomarkers for Alzheimer's Disease: Implications for Clinicians.Vimita Patel, George Grossberg
Missouri Medicine. 2024-11-22 - Profiling aducanumab as a treatment option for Alzheimer's disease: an overview of efficacy, safety and tolerability.Shreeya Thussu, Aniketh Naidu, Sindhu Manivannan, George T Grossberg
Expert Review of Neurotherapeutics. 2024-11-01 - 1 citationsThe donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical review.Austin Buck, Kayvon Rezaei, Aman Quazi, Gary Goldmeier, Bret Silverglate
Expert Review of Neurotherapeutics. 2024-06-01
Journal Articles
- The Cholinergic System in the Pathophysiology and Treatment of Alzheimer’s DiseaseGeorge T Grossberg, Peter J Snyder, Martin R Farlow, Brain
Press Mentions
- New Data on IV Ketamine for Resistant Depression in the ElderlyMarch 14th, 2023
- LUCIDITY Phase 3 Topline Data Presented at CTAD for HMTM - the Only Oral Anti-Tau Therapy in Late-Stage DevelopmentNovember 30th, 2022
- Avoiding Alzheimer’s: Lifestyle Modifications You Can Make TodaySeptember 22nd, 2022
- Join now to see all
Other Languages
- Hebrew, Hungarian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: